BNP Paribas Financial Markets’s Alamar Biosciences ALMR Stock Holding History

BNP Paribas Financial Markets’s Portfolio ALMR Stock Details ALMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$55K	Buy	+2,031	New	+$46K	﹤0.01%	4840

Other funds holding ALMR

SCV

Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BNP Paribas Financial Markets's ALMR Position: Q2 2026 in Review

BNP Paribas Financial Markets opened a new position in Alamar Biosciences (ALMR) in Q2 2026: 2,031 shares worth $55K. The stake represents ﹤0.01% of the portfolio and ranks #4840 among its holdings.

86 funds tracked by Wall St. Rank hold ALMR as of Q2 2026.

BNP Paribas Financial Markets held 2,031 shares of Alamar Biosciences worth $55K as of Q2 2026.
Alamar Biosciences was a new BNP Paribas Financial Markets position in Q2 2026.
Alamar Biosciences made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #4840 holding.
86 funds tracked by Wall St. Rank held Alamar Biosciences as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.